Meeting the Needs of Justice-Involved People With Serious Mental Illness: In Reply

IN REPLY: As admirers of their work, we thank Drs. Lamberti and Weisman for their comments on our article. We agree that the evolution of forensic assertive community treatment (FACT) they describe is exactly the type of community-based, multi-pronged, comprehensive service approach needed to address the high rates of justice involvement among people with serious mental illness. We also agree that the FACT service delivery model as described by the Substance Abuse and Mental Health Services Administration (SAMHSA) is one example of how our proposed vision can be put into action

Meeting the Needs of Justice-Involved People With Serious Mental Illness Within Community Behavioral Health Systems

The overrepresentation of people with serious mental illness in the criminal justice system is a complex problem. A long-standing explanation for this phenomenon, the criminalization hypothesis, posits that policy changes that shifted the care of people with serious mental illness from psychiatric hospitals to an underfunded community treatment setting resulted in their overrepresentation within the criminal justice system. This framework has driven the development of interventions to connect people with serious mental illness to needed mental health and substance use treatment, a critical component for people in need. However, the criminalization hypothesis is a limited explanation of the overrepresentation of people with serious mental illness in the criminal justice system because it downplays the social and economic forces that have contributed to justice system involvement in general and minimizes the complex clinical, criminogenic, substance use, and social services needs of people with serious mental illness. A new approach is needed that focuses on addressing the multiple factors that contribute to justice involvement for this population. Although the authors' proposed approach may be viewed as aspirational, they suggest that an integrated community-based behavioral health system-i.e., intercept 0-serve as the focal point for coordinating and integrating services for justice-involved people with serious mental illness

Diversity in case management modalities: the Summit model

Though ubiquitous in community mental health agencies, case management suffers from a lack of consensus regarding its definition, essential components, and appropriate application. Meaningful comparisons of various case management models await such a consensus. Global assessments of case management must be replaced by empirical studies of specific interventions with respect to the needs of specific populations. The authors describe a highly differentiated and prescriptive system of case management involving the application of more than one model of service delivery. Such a diversified and targeted system offers an opportunity to study the technology of case management in a more meaningful manner

Community treatment orders for patients with psychosis (OCTET): a randomised controlled trial

The trial is funded by a Programme Grant for Applied Research from the National Institute of Health Research (RP-PG-0606–1006

Introduction to this double issue: Jail diversion and collaboration across the justice continuum

Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/142041/1/bsl2322.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/142041/2/bsl2322_am.pd

A prospective observational study protocol to investigate long-term adverse effects of methylphenidate in children and adolescents with ADHD:The Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study

Introduction: Methylphenidate is the most frequently used medication for the treatment of attention-deficit/hyperactivity disorder (ADHD) in Europe. Following concerns about its safety, the European Commission called for research into the long-term effects of methylphenidate on children and adolescents with ADHD. The Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) research programme was designed to address this call. At the heart of this programme is a 2-year longitudinal naturalistic pharmacovigilance study being conducted in 27 European sites.Methods and analysis: 3 cohorts of children and adolescents (aged 6–17) living in the UK, Germany, Italy and Hungary are being recruited:Group 1 (Medicated ADHD): 800 ADHD medication-naive children and adolescents with a clinical diagnosis of ADHD about to start methylphenidate treatment for the first time.Group 2 (Unmedicated ADHD): 400 children and adolescents with a clinical diagnosis of ADHD who have never been treated with ADHD medication and have no intention of beginning medication.Group 3 (Non-ADHD): 400 children and adolescents without ADHD who are siblings of individuals in either group 1 or 2.All participants will be assessed 5 times during their 2-year follow-up period for growth and development, psychiatric, neurological and cardiovascular health. The primary outcome measure will be the height velocity SD score.Ethics and dissemination: Ethical approval for the study has been granted by the East of Scotland Research Ethics Service. Following this approval, patient information leaflets and consent forms were translated as necessary and submissions made by lead sites in each of the other 3 countries to their own ethics committees. Following ethical approval in each country, local ethical permissions at each site were sought and obtained as needed. The study's website (http://www.adhd-adduce.org/page/view/2/Home) provides information for researchers, participants and the general public.Trial registration number: NCT01470261.<br/

Carbamazepine for schizophrenia (Review)

Many people with schizophrenia do not achieve a satisfactory treatment response with just antipsychotic drug treatment and various adjunct medications are used to promote additional response. The antiepileptic carbamazepine is one such dru

Between Place: Food Consumption and Spaces of Inclusion and Exclusion in Montpellier, France

Includes bibliography?If you are lucky enough to have lived in Paris as a young man, then wherever you go for the rest of your life, it stays with you, for Paris is a moveable feast,? wrote Ernest Hemingway about his time there in the 1920s.1 He surely had more in mind than profiteroles, foie gras, and terrines when he penned these words. Hemingway?s Paris was electric, pulsing with the caf? culture of the Left Bank at the pinnacle of the modern age. This was Paris?a Bohemian, exuberant ideal of how it must be to live as an expatriate, especially an American, in France. What Hemingway attempted to capture with words, George Gershwin set to music. The melodies of An American in Paris, composed in 1928, evoke a traveller?s path through the city at that time.2 If you have a musical imagination, perhaps you can feel the place in that era through Gershwin?s tone poem; or if you are a more literary sort, maybe you can picture Hemingway?s city?in the company of Gertrude Stein, F. Scott Fitzgerald, and Pablo Picasso. Such a place now exists only as sets of recollections. Yet this Paris of the past lives on. What is more, this long-past or maybe merely mythic capital and all of its romantic evocations are projected onto the entire country, if only in our minds. This is what it must be like to live as a foreigner in France